Search Results 1041-1050 of 16296 for Chronic Lymphocytic Leukemia

  1. Ovarian and Uterine Cancer Patients' Cancer Diagnosis and Treatment-Related Characteristics from Medical Records - Mayo Clinic

    The purpose of this study is to extract ovarian and uterine cancer patients' phenotypes at diagnosis and cancer treatments (side-effects, symptoms and clinical ...

  2. Cancer - Doctors and departments - Mayo Clinic

    Chronic Lymphoproliferative Disorders Group · Clinical Genomics · Colon and ... Leukemia, Acute lymphocytic le...ukemia, Acute myelogenous leukemia. Show ...

  3. IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome - Mayo Clinic

    ... chronic myelomonocytic leukemia (CMML) and oligoblastic acute myelogenous leukemia (oligoblastic AML or O-AML), including determining the maximum tolerated ...

  4. Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells - Mayo Clinic

    About this study. This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to ...

  5. Pediatric Hematology/Oncology - Overview - Mayo Clinic

    Leukemia and Lymphoma Program. Our pediatric ... They work closely with hematopathologists to comprehensively analyze samples, which ensures accurate diagnosis ...

  6. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    The purpose of this study with a 28-week Open-label Extension of BLU-5937 in adult (18 to 80 years of age) participants who have had persistent cough for ≥ 1 ...

  7. A Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients with Primary Biliary Cirrhosis

    Phase 4 trials look at long-term safety and effectiveness, after a new ... chronic lymphatic leukemia); History or presence of clinically concerning ...

  8. Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Mayo Clinic

    ... chronic myelogenous leukemia (CML or BCR/ABL), are not eligible; Patients must have disease present in the blood or bone marrow; patients with only ...

  9. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

    A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT).

  10. Patient with "Double Trouble" Diagnosis Finds Answers at Mayo Clinic

    Being diagnosed with multiple myeloma, a serious blood cancer, is difficult enough to accept. But being told that you also have a rare hematologic condition ...